NEW YORK – With the launch of its first product, a rule-out test for pancreatic cysts that can help risk-stratify patients who may have pancreatic cancer, Purdue University spinout Amplified Sciences ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

BRANDENBERG, Maddock and Schweitzer 1 reported the treatment by transgastric cyst gastrostomy of 2 patients with pancreatic pseudocysts and pancreatitis in 1951. Maddock suggested this procedure ...

Most pancreatic cancers have no clear symptoms, which results in a delayed diagnosis. About one fourth, however, begin as cysts that could develop into pancreatic cancer. The challenge is to ...

Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced additional results from the successful VERIFI study of its next-generation pancreatic cancer test, ...

such as a pancreatic cyst. "A cyst is a small fluid collection. Most cysts are benign, but there is a small subset that can turn malignant," says Dr. Wallace. Dr. Wallace and his colleagues around ...

and people with pancreatic cysts: "The combined test performance data from CLARIFI and VERIFI represents a key milestone for Immunovia: demonstrating excellent test accuracy across multiple groups ...

pancreatic cysts (fluid-filled sacs in the pancreas that sometimes develop into pancreatic cancer), or a combination of these risk factors. About Pancreatic Cancer Pancreatic cancer is one of the ...

pancreatic cysts (fluid-filled sacs in the pancreas that sometimes develop into pancreatic cancer), or a combination of these risk factors. Pancreatic cancer is one of the most aggressive cancers ...

and people with pancreatic cysts: "The combined test performance data from CLARIFI and VERIFI represents a key milestone for Immunovia: demonstrating excellent test accuracy across multiple groups of ...